col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


76 Results       Page 1

 [1] 
Springer-Verlag: VirusDisease
  original article Date Title Authors   All Authors
1 [GO] 2022―Apr―06 Respiratory viral infections other than SARS CoV-2 among the North Indian patients presenting with acute respiratory illness during the first COVID-19 wave Monika Sapra, Sangeetha Kirubanandhan, Poonam Kanta, Arnab Ghosh, Kapil Goyal, Mini P. Singh, R. K. Ratho
2 [GO] 2022―Feb―01 A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, Asma Talukder
3 [GO] 2022―Jan―21 Computational screening of potential drugs against COVID-19 disease: the Neuropilin-1 receptor as molecular target Hicham Charoute, Zouhair Elkarhat, Lamiae Elkhattabi, Elmostafa El Fahime, Naoual Oukkache, Hassan Rouba, Abdelhamid Barakat
4 [GO] 2021―Nov―05 Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2 Debadrita Paul, Nibedita Pyne, Santanu Paul
5 [GO] 2021―Oct―25 MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses Mahdiyar Iravani Saadi, Mani Ramzi, Zahra Hesami, Nadiya kheradmand, Maryam Owjfard, Ehsan Nabi Abdolyousefi, Zahed Karimi
6 [GO] 2021―Sep―24 Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy Mukul Kumar Singh, Mayank Jain, Hari Shyam, Pratap Shankar, Vishwajeet Singh
7 [GO] 2021―Sep―21 Correction to: Do inflammasome impact COVID-19 severity? Maria Beatriz Calado, Crislayne Emilly da Silva Santana, Sergio Crovella
8 [GO] 2021―Sep―20 Prospective evaluation of specimen pooling strategy for detection of SARS-CoV-2 using pools of five and six specimens Georgios Meletis, Styliani Pappa, Maria Exindari, Georgia Gioula, Evangelia Giosi, Antonios Katsoulas, et al. (+2)
9 [GO] 2021―Sep―07 Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes Aditya Agrawal, Rajat Varshney, Mamta Pathak, Shailesh Kumar Patel, Vishal Rai, Sourabh Sulabh, et al. (+4)
10 [GO] 2021―Aug―18 Diagnostic performance of lung ultrasound compared to CT scan in the diagnosis of pulmonary lesions of COVID-19 induced pneumonia: a preliminary study Jafar Roshandel, Sam Alahyari, Mehdi Khazaei, Reyhane Asgari, Yashar Moharamzad, Ehsan Zarei, Morteza Sanei Taheri
11 [GO] 2021―Jul―31 Potential drug leads for SARS-CoV2 from phytochemicals of Aerva lanata: a Machine Learning approach D. R. Sherin, N. Sharanya, T. K. Manojkumar
12 [GO] 2021―Jul―26 Dentistry pathways of coronaviruses transmission: a review Zahra Setayesh-Mehr, Mahdiye Poorsargol
13 [GO] 2021―Jul―26 Do inflammasome impact COVID-19 severity? Maria Beatriz Calado, Crislayne Emilly da Silva Santana, Sergio Crovella
14 [GO] 2021―Jul―26 Computational Identification of SARS-CoV-2 Inhibitor in Tinospora cordifolia, Cinnamomum zeylanicum and Myristica fragrans Viswajit Mulpuru, Nidhi Mishra
15 [GO] 2021―Jul―22 COVID-19 gripped the globe with some unnoticed facts and too many questions Awanish Kumar
16 [GO] 2021―Jul―15 Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach Swetha Pulakuntla, Kiran Bharat Lokhande, Pannuru Padmavathi, Meena Pal, Kakumani Venkateswara Swamy, Jayashree Sadasivam, et al. (+3)
17 [GO] 2021―Jul―15 Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2 Buddha Bahadur Basnet, Rajesh Basnet, Raju Panday
18 [GO] 2021―Jul―13 A theoretical strategy for acceleration of human immune response against SARS-CoV-2: a fusion protein harboring virus-binding and pre-exposed antigen domains Reza Rahmani, Neda Eivazi, Maliheh Paknejad, Mahdi Aminian
19 [GO] 2021―Jul―01 Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (Mpro) Misbaudeen Abdul-Hammed, Ibrahim Olaide Adedotun, Victoria Adeola Falade, Adewusi John Adepoju, Sabitu Babatunde Olasupo, Modinat Wuraola Akinboade
20 [GO] 2021―Jun―25 Attitude and associated factors of COVID-19 vaccine acceptance among health professionals in Debre Tabor Comprehensive Specialized Hospital, North Central Ethiopia; 2021: cross-sectional study Yewlsew Fentie Alle, Keder Essa Oumer
21 [GO] 2021―Jun―24 Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view Sonali Bhattacharya, Sudipta Majumdar Nee Paul
22 [GO] 2021―Jun―24 Why Is Hormone Therapy Successful Strategy Against Coronavirus-19? Gholamreza Asadikaram, Mohammad Kazemi Arababadi
23 [GO] 2021―Jun―23 In vitro antiviral activities of ethanol and aqueous extracts of Vietnamese traditional medicinal plants against Porcine Epidemic Diarrhea virus: a coronavirus family member Thi Bich Ngoc Trinh, Diep Hong Le, Thanh Thi Kim Nguyen, Van Tam Nguyen, Minh Hong Nguyen, Marc Muller, et al. (+3)
24 [GO] 2021―Jun―09 SARS-Cov2: a meta-analysis of symptom distribution by continent in 7310 adult COVID-19 infected patients Hitesh Singhavi, Ameya Pai, Manish Mair, Jinesh Singhavi, Prachi Gandhi, Andrew Baker, et al. (+3)
25 [GO] 2021―Jun―05 Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s) Swaraj Mohanty, Subhojit Paul, Yasmin Ahmad
26 [GO] 2021―Jun―04 Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between inflammation, mTOR pathway, autophagy and calorie restriction Martin Gnoni, Renato Beas, Raúl Vásquez-Garagatti
27 [GO] 2021―Jun―03 Assessment of nitric oxide (NO) potential to mitigate COVID-19 severity Swati Srivastava, Iti Garg, Anju A. Hembrom, Bhuvnesh Kumar
28 [GO] 2021―May―25 The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship Supram Hosuru Subramanya, Daniel M. Czyż, Krishna Prasad Acharya, Hilary Humphreys
29 [GO] 2021―May―05 Exploring status of emergency drugs and vaccine development in Covid-19 pandemic: an update Alok Sharma, Suhail Ahmed, Jasleen Kaur, Rakesh Chawla, Chandrababu Rejeeth
30 [GO] 2021―May―04 Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection Utkarsha Sahu, Debasis Biswas, Anirudh Kumar Singh, Prashant Khare
31 [GO] 2021―May―03 Detection of SARS-CoV-2 infection by RT-PCR test: factors influencing interpretation of results Kiran Munne, Venkanna Bhanothu, Vikrant Bhor, Vainav Patel, Smita D. Mahale, Shailesh Pande
32 [GO] 2021―Apr―29 Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors Mahmoud Hamed, Mahmoud El-Hasab, Fotouh R. Mansour
33 [GO] 2021―Apr―29 A new emerging pandemic of severe fever with thrombocytopenia syndrome (SFTS) Divya Sharma, Mohit Kamthania
34 [GO] 2021―Apr―22 SARS-CoV-2 aerosol and droplets: an overview Udaykumar Ranga
35 [GO] 2021―Apr―10 Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for Covid-19 Peter Ifeoluwa Adegbola, Banjo Semire, Olumide Samuel Fadahunsi, Aanuoluwa Eunice Adegoke
36 [GO] 2021―Apr―07 COVID-19 infection in a HIV positive health care worker: first case report from a tertiary care hospital of North India Ritin Mohindra, Poonam Kanta, Pradakshana Porchezhian, Kapil Goyal, Vikas Suri, Mini P. Singh, et al. (+2)
37 [GO] 2021―Apr―05 In silico approach to understand the epigenetic mechanism of SARS-CoV-2 and its impact on the environment Sahar Qazi, Kayenat Sheikh, Khalid Raza
38 [GO] 2021―Mar―22 Vaccines and drugs under clinical trials for prevention and treatment of COVID-19 Umesh C. S. Yadav
39 [GO] 2021―Mar―20 Computationally approached inhibition potential of Tinospora cordifolia towards COVID-19 targets Sushovan Jena, Punnagai Munusami, Balamurali MM, Kaushik Chanda
40 [GO] 2021―Mar―18 A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery U. Rutwick Surya, N. Praveen
41 [GO] 2021―Mar―17 Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID-19 Vikram Thakur, Radha Kanta Ratho, Jiban Jyoti Panda
42 [GO] 2021―Mar―10 Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus Ritu Ghildiyal, Reema Gabrani
43 [GO] 2021―Mar―04 Evaluation of diagnostic accuracy of developed rapid SARS-COV-2 IgG antibody test kit using novel diluent system Vani Maya, Jyothi Embekkat Kaviyil, Dinoop Koral Ponnambath, Renjith P. Nair, Anugya Bhatt, Rajendra Pilankatta, et al. (+4)
44 [GO] 2021―Feb―22 SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology Amit Kumar Sahu, M. Sreepadmanabh, Mahendra Rai, Ajit Chande
45 [GO] 2021―Feb―18 Cognitive assessment in asymptomatic COVID-19 subjects Sridhar Amalakanti, Kesava Venkata Raman Arepalli, Jyothi Priya Jillella
46 [GO] 2021―Jan―28 In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19 Vipul Kumar, Sudhakar Kancharla, Manoj Kumar Jena
47 [GO] 2020―Dec―07 Molecular characterisation of porcine reproductive and respiratory syndrome virus from pigs in Kerala G. Chaithra, Chintu Ravishankar, Stephy Rose Sebastian, R. Rajasekhar, R. Anoopraj, Binu K. Mani, et al. (+5)
48 [GO] 2020―Dec―05 Chasing COVID-19 through SARS-CoV-2 spike glycoprotein Shailendra K. Saxena, Swatantra Kumar, Preeti Baxi, Nishant Srivastava, Bipin Puri, R. K. Ratho
49 [GO] 2020―Dec―02 Selection of animal models for COVID-19 research Suresh Kumar, Pardeep Kumar Yadav, Ramesh Srinivasan, Nagarajan Perumal
50 [GO] 2020―Nov―11 Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters Nabanita Roy Chattopadhyay, Koustav Chatterjee, Antara Banerjee, Tathagata Choudhuri
51 [GO] 2020―Nov―11 Structure-guided discovery approach identifies potential lead compounds targeting Mpro of SARS-CoV-2 Mohcine Elmessaoudi-Idrissi, Kyoko Tsukiyama-Kohara, Jalal Nourlil, Anass Kettani, Marc P. Windisch, Michinori Kohara, et al. (+4)
52 [GO] 2020―Oct―16 SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations Sarayu Krishnamoorthy, Basudev Swain, R. S. Verma, Sachin S. Gunthe
53 [GO] 2020―Oct―16 2019-nCoV: a worldwide concern and facts Rajani Sharma, Gargi Akhoury
54 [GO] 2020―Sep―11 SARS-CoV-2 infection: physiological and environmental gift factors at high altitude Swati Srivastava, Iti Garg, Anju Bansal, Bhuvnesh Kumar
55 [GO] 2020―Aug―08 Ramping up of SARS CoV-2 testing for the diagnosis of COVID-19 to better manage the next phase of pandemic and reduce the mortality in India Senthilkumar Natesan, Ragini Bhatia, Aarthi Sundararajan, Kuldeep Dhama, Yashpal S. Malik, Kranti Vora
56 [GO] 2020―Jun―26 The global emergence of severe acute respiratory syndrome coronavirus 2 in human Bikash Mandal
57 [GO] 2020―Jun―23 Emerging coronavirus diseases and future perspectives Shireen Akhter, Shahzeen Akhtar
58 [GO] 2020―Jun―22 Decoding the global outbreak of COVID-19: the nature is behind the scene Piyanki Das, Tathagata Choudhuri
59 [GO] 2020―Jun―13 COVID-19 diagnostic approaches: different roads to the same destination Ramesh Kumar, Suman Nagpal, Samander Kaushik, Sanjay Mendiratta
60 [GO] 2020―Jun―11 Relevance of SARS-CoV-2 in food safety and food hygiene: potential preventive measures, suggestions and nanotechnological approaches Zafer Ceylan, Raciye Meral, Turgay Cetinkaya
61 [GO] 2020―Jun―11 Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era Dinesh Kumar Rajendran, Varthini Rajagopal, S. Alagumanian, T. Santhosh Kumar, S. P. Sathiya Prabhakaran, Dharun Kasilingam
62 [GO] 2020―Jun―10 Statistical analysis and visualization of the potential cases of pandemic coronavirus R. Muthusami, K. Saritha
63 [GO] 2020―Jun―05 Inanimate surfaces as potential source of 2019-nCoV spread and their disinfection with biocidal agents Muhammad Zeeshan Akram
64 [GO] 2020―May―24 Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor Vimal K. Maurya, Swatantra Kumar, Anil K. Prasad, Madan L. B. Bhatt, Shailendra K. Saxena
65 [GO] 2020―May―22 What we know about 2019-nCoV in Iran in the early stage? Milad Dodangeh, Masoud Dodangeh, Mohammadamin Joulani, Azinmehr Elahian Boroujeni
66 [GO] 2020―May―12 Human coronaviruses with emphasis on the COVID-19 outbreak Saraj Bahadur, Wenxing Long, Muhammad Shuaib
67 [GO] 2020―May―06 The dipeptidyl peptidase-4 expression in some MERS-CoV naturally infected dromedary camels in Saudi Arabia 2018-2019 Abdelmohsen Alnaeem, Samy Kasem, Ibrahim Qasim, Ali Al-Doweriej, Mohamed Refaat, Abdulkareem Al-Shabebi, Maged Gomaa Hemida
68 [GO] 2020―May―04 The Indian perspective of COVID-19 outbreak Samander Kaushik, Sulochana Kaushik, Yashika Sharma, Ramesh Kumar, Jaya Parkash Yadav
69 [GO] 2020―May―04 The molecular biology of intracellular events during Coronavirus infection cycle Juhi Jain, Sharad Gaur, Yash Chaudhary, Rajeev Kaul
70 [GO] 2020―May―02 Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock Dipti Mothay, K. V. Ramesh
71 [GO] 2020―Apr―20 One month of the novel coronavirus 2019 outbreak: Is it still a threat? Apu Chowdhury, Nabila Jahan, Sicen Wang
72 [GO] 2020―Apr―20 Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives Khadga Raj, Anirban Ghosh, Shamsher Singh
73 [GO] 2020―Apr―20 Coronavirus threat to Indian population: risk factors, transmission dynamics and preparedness to prevent the spread of the virus Dibyakanti Mandal
74 [GO] 2020―Apr―18 Recent apprise on coronavirus and its terrible insinuations Sankha Bhattacharya, Priyanka Sharma, Harshita Mathur, Haamid Rasheed, Saranjit Singh, Geeta Rajput, et al. (+3)
75 [GO] 2020―Apr―08 Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020 Arshi Islam, Anwar Ahmed, Irshad H. Naqvi, Shama Parveen
76 [GO] 2020―Mar―05 Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV) Swatantra Kumar, Vimal K. Maurya, Anil K. Prasad, Madan L. B. Bhatt, Shailendra K. Saxena
 [1] 

76 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.018 sec